Author: OurCrowd

[Insightec in PR Newswire] INSIGHTEC Announces FDA Approval of Exablate Neuro for the Treatment of Tremor-Dominant Parkinson’s Disease

INSIGHTEC, a global medical technology innovator of incisionless surgery, today announced that The Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) has approved an expansion of the indication of Exablate Neuro to include the treatment of patients with tremor-dominant Parkinson’s disease (PD). Read more on PR...

Read More

Latest from Twitter

  • RT @jonmedved: “The lesson of the past seven months is that anyone who thinks they can predict the future with any clarity is wrong. Digita…
  • RT @jonmedved: This @OurCrowd company is making the world a sweeter, healthier place. @DouxMatok CEO Eran Baniel and his father, co-founder…
  • RT @jonmedved: “The unlocking of the energies between these two countries will be huge. Because let's face it, Israel punches above its wei…